34 results
8-K
EX-1.1
YTEN
Yield10 Bioscience Inc
15 Mar 19
Yield10 Bioscience Announces Pricing of $2.9 Million Registered Direct Offering
9:25am
with the transactions contemplated hereby, including, without limitation: (i) all expenses incident to the issuance, delivery and qualification of the Securities … ) if applicable, the filing fees incident to the review and approval by the FINRA of the Placement Agent’s participation in the offering and distribution
8-K
EX-10.1
YTEN
Yield10 Bioscience Inc
25 Aug 20
Yield10 Bioscience Announces Pricing of $5.2 Million Public Offering and Concurrent Private Placement
4:10pm
and expenses of counsel for the Company, blue sky fees and expenses and the expense of any special audits incident to or required by any such registration … or supplement thereof, or other document incident to any registration, qualification or compliance or based on any omission (or alleged omission) to state
8-K
EX-10.1
YTEN
Yield10 Bioscience Inc
20 Nov 19
Yield10 Bioscience Announces Closing of $11.5 Million Equity Offering and Full Exercise of Over-allotment Option
12:00am
audits incident to or required by any such registration (but excluding the fees of legal counsel for any Investor or holder of Registrable Shares … in any Registration Statement, prospectus, any amendment or supplement thereof, or other document incident to any registration, qualification
8-K
EX-10.1
vydpdax14piw0qivs
4 Aug 14
Metabolix, Inc. Enters into Private Placement Agreement with Investors to Raise $25 Million in Equity Financing
12:00am
8-K
EX-10.1
xtlivng fxj
7 Oct 15
Metabolix, Inc. Announces $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
12:00am
8-K
EX-1.1
imzotr
19 May 11
Metabolix Prices Common Stock Offering
12:00am
8-K
EX-10.1
v0yw9o0u
11 Aug 23
Yield10 Bioscience Announces Pricing of $3.7 Million Public Offering
5:22pm
424B3
qceer7bx6px
18 Jul 23
Prospectus supplement
2:38pm
8-K
EX-1.1
7xgf2c1zk 8dpqv
12 Nov 09
Metabolix Announces Commencement of Public Offering of Common Stock
12:00am
S-1
EX-10.6
9haz8p
14 Jul 06
IPO registration
12:00am
8-K
EX-10.1
buvtvqd5
15 Mar 19
Yield10 Bioscience Announces Pricing of $2.9 Million Registered Direct Offering
9:25am
S-1/A
EX-10.15
ouxv nxxqdelx33x
31 Aug 06
IPO registration (amended)
12:00am